SCHEMBL23333903

SCHEMBL23333903

C/C(=N\NC(C)C)c1ccc(C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ STAT1 P42224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23392921 1.00 RAB9A (0.43) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL23392919 1.00 RAB9A (0.43) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL17276528 0.82 MAPT (0.55) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL25581428 0.81 RXFP1 (0.42) L3MBTL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL27045464 0.79 ALDH1A1 (0.63) RAB9AL3MBTL1ALDH1A1MAPTMEN1
SCHEMBL16595860 0.78 MAPT (0.43) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL21164826 0.78 ALDH1A1 (0.37) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL25581431 0.78 KMT2A (0.49) RAB9AALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL24000933 0.77 ALDH1A1 (0.44) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT
SCHEMBL15177203 0.73 ALDH1A1 (0.54) RAB9AL3MBTL1ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212644-B1 DERIVATIVES OF 2-(1,2,4-TRIAZOL-3-YLSULFANYL)-N-1,3,4-THIADIAZOL-2-YL ACETAMIDE WHICH ARE USEFUL FOR THE TREATMENT OF DIABETES APOGLYX AB (SE) 2021-05-05 — — EP disclosed
Send feedback